Individuals can respond differently to the same medication
PHARMACOGENETIC TESTING, ALSO CALLED PHARMACOGENOMIC TESTING, CAN PROVIDE CLINICIANS WITH MEDICATION GUIDANCE FOR A DESIRED RESPONSE
With our reporting, providers can assess gene-drug and drug-drug-gene interactions for a personalized targeted approach to patient care
Pharmacogenetic Test Report
Evidence-based PGx report with medication & dosing recommendations based on a patient’s known genotypes
Personal Pharmacogenetics Information Wallet Card provided for each patient
Recommendations adjusted for concomitant inhibitors & inducers
Portable & sharable results for patients
We only report evidence-based prescribing guidelines provided by the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), and the US Food & Drug Administration (FDA)
PGx TEST DETAILS
15 TEST MARKERS
ABCG2
CYP2C9
CYP2C19
CYP2D6
CYP2B6
CYP3A4
CYP3A5
DPYD
F2
F5
G6PD
NUDT15
SLCO1B1
TPMT
VKORC1
Methodology
Real-time polymerase chain reaction (PCR)
Specimen​
Buccal swab
​
Patient Preparation
Wait 30 minutes after eating, drinking, smoking or chewing gum before taking sample
​
Stability
60 days - room temperature
​
Transport Temperature
Room temperature
Genetic makeup determines the type and quantity of cell receptors a person has, which may have an impact on how a medication affects that individual.
How do patients respond to medications?
BASED ON PHARMACOGENETIC RESULTS, CLINICIANS MAY PRESCRIBE A DIFFERENT MEDICINE, OR A GREATER OR LOWER DOSAGE FOR PATIENTS
.webp)
